In addition, an increased expression of xCT has been described in an animal model of Parkinson's disease [42] and in reactive microglia located in amyloid plaques of transgenic mice expressing mutant human amyloid precursor protein, as well as in wild-type mice injected with amyloid-β [26]. This evidence concerns the gene APP and Parkinson disease.